| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 130 |
| 1 | NIRAPARIB | 48 |
| 2 | ARIPIPRAZOLE ORAL | 45 |
| 3 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 45 |
| 4 | TOLVAPTAN | 44 |
| 5 | CLOZAPINE | 42 |
| 6 | OLANZAPINE | 42 |
| 7 | FINGOLIMOD HCL | 33 |
| 8 | LORAZEPAM | 30 |
| 9 | ESKETAMINE HYDROCHLORIDE | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGZILARGINASE-NBLN | 2 | 0.0645 |
| 1 | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, AND SODIUM BICARBONATE | 1 | 0.0167 |
| 2 | CANTHARIDIN | 1 | 0.0055 |
| 3 | TALIGLUCERASE ALFA | 3 | 0.0052 |
| 4 | CLORAZEPATE DIPOTASSIUM | 6 | 0.0030 |
| 5 | TOLVAPTAN | 44 | 0.0029 |
| 6 | ESTRADIOL AND NORETHINDRONE ACETATE | 1 | 0.0026 |
| 7 | DOBUTAMINE HYDROCHLORIDE | 3 | 0.0023 |
| 8 | FLUPHENAZINE DECANOATE | 1 | 0.0023 |
| 9 | RIFABUTIN | 6 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 168 |
| 1 | Benzodiazepine [EPC] | 44 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 44 |
| 3 | Loop Diuretic [EPC] | 27 |
| 4 | Corticosteroid [EPC] | 26 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 6 | Anti-epileptic Agent [EPC] | 18 |
| 7 | Proton Pump Inhibitor [EPC] | 17 |
| 8 | Aldosterone Antagonist [EPC] | 16 |
| 9 | Alkylating Drug [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 44 | 0.0029 |
| 1 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 2 | Rifamycin Antimycobacterial [EPC] | 6 | 0.0017 |
| 3 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 6 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 7 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 9 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 3 | 0.0007 |